• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多模态诱发电位评估多发性硬化症的病情进展:一项纵向研究

Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.

作者信息

Leocani L, Rovaris M, Boneschi F M, Medaglini S, Rossi P, Martinelli V, Amadio S, Comi G

机构信息

Department of Neurology, Clinical Neurophysiology and Neurorehabilitation, Scientific Institute Hospital San Raffaele, University Vita-Salute, Milan, Italy.

出版信息

J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1030-5. doi: 10.1136/jnnp.2005.086280. Epub 2006 May 30.

DOI:10.1136/jnnp.2005.086280
PMID:16735397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2077734/
Abstract

BACKGROUND

Evoked potentials are used in the functional assessment of sensory and motor pathways. Their usefulness in monitoring the evolution of multiple sclerosis has not been fully clarified.

OBJECTIVE

The aim of this longitudinal study was to examine the usefulness of multimodal evoked potential in predicting paraclinical outcomes of disease severity and as a prognostic marker in multiple sclerosis.

METHODS

Eighty four patients with clinically definite multiple sclerosis underwent Expanded Disability Status Scale (EDSS) and functional system scoring at study entry and after a mean (standard deviation) follow-up of 30.5 (11.7) months. Sensory and motor evoked potentials were obtained in all patients at study entry and at follow-up in 64 of them, and quantified according to a conventional score.

RESULTS

Cross-sectionally, the severity of each evoked potential score significantly correlated with the corresponding functional system (0.32 < R < 0.60, p < 0.01, for all but follow-up visual evoked potential) and with EDSS (0.34 < R < 0.61; p < 0.001 for all but brain stem evoked potential). EDSS significantly correlated with global evoked potential score severity (baseline R = 0.60, follow-up R = 0.46, p < 0.001). Using longitudinal analysis, only changes in somatosensory evoked potential scores were significantly correlated with changes of sensory functional system (R = 0.34, p = 0.006). However, patients with multiple sclerosis with disability progression at follow-up had more severe baseline evoked potential scores than patients who remained stable. Patients with severe baseline global evoked potential score (higher than the median value) had a risk of 72.5% to progress on disability at follow-up, whereas patients with multiple sclerosis with lower scores had a risk of only 36.3%.

CONCLUSIONS

These results suggest that evoked potential is a good marker of the severity of nervous damage in multiple sclerosis and may have a predictive value regarding the evolution of disability.

摘要

背景

诱发电位用于感觉和运动通路的功能评估。其在监测多发性硬化症病情进展中的作用尚未完全明确。

目的

这项纵向研究的目的是检验多模式诱发电位在预测疾病严重程度的辅助临床结果以及作为多发性硬化症预后标志物方面的作用。

方法

84例临床确诊的多发性硬化症患者在研究开始时以及平均(标准差)30.5(11.7)个月的随访后进行了扩展残疾状态量表(EDSS)和功能系统评分。所有患者在研究开始时均进行了感觉和运动诱发电位检测,其中64例在随访时再次检测,并根据传统评分进行量化。

结果

横断面分析显示,每个诱发电位评分的严重程度与相应的功能系统显著相关(除随访视觉诱发电位外,所有相关系数R均满足0.32 < R < 0.60,p < 0.01),与EDSS也显著相关(除脑干诱发电位外,所有相关系数R均满足0.34 < R < 0.61;p < 0.001)。EDSS与整体诱发电位评分严重程度显著相关(基线时R = 0.60,随访时R = 0.46,p < 0.001)。采用纵向分析,只有体感诱发电位评分的变化与感觉功能系统的变化显著相关(R = 0.34,p = 0.006)。然而,随访时残疾进展的多发性硬化症患者基线诱发电位评分比病情稳定的患者更严重。基线整体诱发电位评分严重(高于中位数)的患者随访时残疾进展风险为72.5%,而评分较低的多发性硬化症患者风险仅为36.3%。

结论

这些结果表明,诱发电位是多发性硬化症神经损伤严重程度的良好标志物,可能对残疾进展具有预测价值。

相似文献

1
Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.多模态诱发电位评估多发性硬化症的病情进展:一项纵向研究
J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1030-5. doi: 10.1136/jnnp.2005.086280. Epub 2006 May 30.
2
Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.用于多发性硬化症功能量化和预后评估的多模态诱发电位
BMC Neurol. 2016 Jun 1;16:83. doi: 10.1186/s12883-016-0608-1.
3
The utility of multimodal evoked potentials in multiple sclerosis prognostication.多模态诱发电位在多发性硬化症预后中的应用。
J Clin Neurosci. 2013 Nov;20(11):1576-81. doi: 10.1016/j.jocn.2013.01.020. Epub 2013 Jul 1.
4
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?诱发电位对多发性硬化症的功能随访和临床预后有帮助吗?
Acta Neurol Belg. 2017 Mar;117(1):53-59. doi: 10.1007/s13760-016-0650-1. Epub 2016 May 19.
5
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.多模态诱发电位在多发性硬化症中的预后价值:EP 评分。
J Neurol. 2011 Nov;258(11):1933-9. doi: 10.1007/s00415-011-6033-x. Epub 2011 Apr 9.
6
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.通过多模态诱发电位监测多发性硬化症:数字评分系统与顺序评分系统的比较
Clin Neurophysiol. 2016 Mar;127(3):1864-71. doi: 10.1016/j.clinph.2015.11.041. Epub 2015 Dec 10.
7
Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis.多模态诱发电位可测量并预测早期复发缓解型多发性硬化症的残疾进展。
Mult Scler. 2008 May;14(4):553-6. doi: 10.1177/1352458507085758.
8
Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis.体感诱发电位预测多发性硬化残疾的短期进展。
Neurol Sci. 2012 Aug;33(4):887-92. doi: 10.1007/s10072-011-0862-3. Epub 2011 Nov 27.
9
Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval?多模态诱发电位对 MS 残疾的预测:在复发期间还是在无复发间隔期进行研究?
Clin Neurophysiol. 2014 Sep;125(9):1889-92. doi: 10.1016/j.clinph.2013.12.117. Epub 2014 Jan 31.
10
Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.多发性硬化症患者诱发电位的早期异常与未来残疾情况
Mult Scler. 2006 Feb;12(1):58-65. doi: 10.1191/135248506ms1244oa.

引用本文的文献

1
Correspondence of MRI and nTMS With EDSS in Multiple Sclerosis: Longitudinal Follow-Up Study.多发性硬化症中MRI和nTMS与扩展残疾状态量表(EDSS)的相关性:纵向随访研究
Ann Clin Transl Neurol. 2025 Jun;12(6):1240-1255. doi: 10.1002/acn3.70041. Epub 2025 Apr 17.
2
Study protocol: Exploratory trial of Forza™, an osmotin-based nutraceutical as adjuvant for the treatment of progressive multiple sclerosis.研究方案:探索性试验,评估基于渗透素的营养保健品Forza™作为辅助治疗进行性多发性硬化症的效果。
PLoS One. 2025 Feb 27;20(2):e0311214. doi: 10.1371/journal.pone.0311214. eCollection 2025.
3
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress.识别多发性硬化症中再髓鞘化和恢复的生物标志物:进展的衡量标准。
Biomedicines. 2025 Feb 4;13(2):357. doi: 10.3390/biomedicines13020357.
4
Assessing disease progression and treatment response in progressive multiple sclerosis.评估进展性多发性硬化症的疾病进展和治疗反应。
Nat Rev Neurol. 2024 Oct;20(10):573-586. doi: 10.1038/s41582-024-01006-1. Epub 2024 Sep 9.
5
Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review.经颅磁刺激增强多发性硬化症诊断标准的特异性:批判性叙述性评论。
PeerJ. 2024 Mar 29;12:e17155. doi: 10.7717/peerj.17155. eCollection 2024.
6
Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease.多发性硬化症缓解-复发期向进展期转化患者的治疗。
CNS Drugs. 2023 Jan;37(1):69-92. doi: 10.1007/s40263-022-00977-3. Epub 2023 Jan 4.
7
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide.在复发型多发性硬化症的治疗中应用个体化预后预测:实用指南。
Front Immunol. 2022 Sep 27;13:991291. doi: 10.3389/fimmu.2022.991291. eCollection 2022.
8
Anterior optic pathway pathology in CNS demyelinating diseases.中枢神经系统脱髓鞘疾病中的前视神经通路病变。
Brain. 2022 Dec 19;145(12):4308-4319. doi: 10.1093/brain/awac030.
9
Gut microbiota in forty cases of egyptian relapsing remitting multiple sclerosis.40例埃及复发缓解型多发性硬化症患者的肠道微生物群
Iran J Microbiol. 2021 Oct;13(5):632-641. doi: 10.18502/ijm.v13i5.7428.
10
Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis-An Explorative Study.多发性硬化症中氨吡啶反应性的临床、神经生理学和MRI标志物——一项探索性研究
Front Neurol. 2021 Oct 26;12:758710. doi: 10.3389/fneur.2021.758710. eCollection 2021.

本文引用的文献

1
The diagnosis and management of multiple sclerosis.多发性硬化症的诊断与管理
Acta Neurol Scand. 2005 Sep;112(3):199-201. doi: 10.1111/j.1600-0404.2005.00450.x.
2
Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.模式翻转视觉诱发电位作为多发性硬化症视觉通路病变的一种检测手段。
Mult Scler. 2003 Oct;9(5):529-34. doi: 10.1191/1352458503ms935rr.
3
Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.临床多发性硬化症进展的传统及磁化传递磁共振成像预测指标:一项中期随访研究
Brain. 2003 Oct;126(Pt 10):2323-32. doi: 10.1093/brain/awg232. Epub 2003 Aug 22.
4
Somatosensory evoked potentials and sensory involvement in multiple sclerosis: comparison with clinical findings and quantitative sensory tests.体感诱发电位与多发性硬化症中的感觉受累:与临床发现及定量感觉测试的比较
Mult Scler. 2003 Jun;9(3):275-9. doi: 10.1191/1352458503ms908oa.
5
Eight-year follow-up study of brain atrophy in patients with MS.多发性硬化症患者脑萎缩的八年随访研究。
Neurology. 2002 Nov 12;59(9):1412-20. doi: 10.1212/01.wnl.0000036271.49066.06.
6
Continuing optic nerve atrophy following optic neuritis: a serial MRI study.
Mult Scler. 2002 Aug;8(4):339-42. doi: 10.1191/1352458502ms809oa.
7
Visual and motor evoked potentials in the course of multiple sclerosis.多发性硬化病程中的视觉和运动诱发电位
Brain. 2001 Nov;124(Pt 11):2162-8. doi: 10.1093/brain/124.11.2162.
8
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.多发性硬化症推荐诊断标准:国际多发性硬化症诊断小组指南
Ann Neurol. 2001 Jul;50(1):121-7. doi: 10.1002/ana.1032.
9
Age-related changes of evoked potentials.
Neurophysiol Clin. 2001 Apr;31(2):83-103. doi: 10.1016/s0987-7053(01)00248-9.
10
EDSS correlated analysis of median nerve somatosensory evoked potentials in multiple sclerosis.多发性硬化症中正中神经体感诱发电位的扩展残疾状态量表相关性分析
Neurol Sci. 2000 Aug;21(4):217-21. doi: 10.1007/s100720070079.